Company: BGLC
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003821
Chunk: 87

Company: BioNexus Gene Lab Corp
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 6
Chunk 87
---
Exhibit Description   31.1 Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**   32.1 Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002+**   101.INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).*   101.SCH Inline XBRL Taxonomy Extension Schema Document.*   101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.*   101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.*   101.LAB Inline XBRL Taxonomy Extension Labels Linkbase Document.*   101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.*   104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).*

______________

+ In accordance with SEC Release 33-8238, Exhibit 32.1 and 32.2 were furnished and not filed.

** Previously filed or furnished as an exhibit to BioNexus Gene Lab Corp.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 . * Furnished with this Form 10-Q.

 39Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

BIONEXUS GENE LAB CORPORATION  /s/ Su-Leng Tan LeeSu-Leng Tan Lee Chief Executive Officer (Principal Executive Officer)   /s/ Su-Leng Tan Lee Su-Leng Tan Lee Acting Chief Financial Officer (Principal Financial and Accounting Officer) 

May 15, 2025

 40